Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.38M Sell
7,060
-543
-7% -$107K 0.25% 52
2026
Q2
$2.29M Buy
7,603
+3
+0% +$596 0.4% 33
2026
Q1
$1.12M Buy
7,600
+230
+3% +$33.6K 0.24% 61
2025
Q4
$895K Buy
7,370
+3,090
+72% +$362K 0.21% 73
2025
Q3
$461K Sell
4,280
-50
-1% -$4.66K 0.19% 107
2025
Q2
$388K Buy
4,330
+270
+7% +$20.3K 0.18% 115
2025
Q1
$276K Buy
+4,060
New +$292K 0.17% 113
2024
Q4
– Sell
-2,710
Closed -$210K – 178
2024
Q3
$210K Buy
2,710
+30
+1% +$2.35K 0.14% 132
2024
Q2
$221K Buy
+2,680
New +$198K 0.16% 111

Other funds holding KLAC

Abel Hall LLC's KLAC Position: Q3 2026 in Review

Abel Hall LLC reduced its KLA (KLAC) stake by 7.1% in Q3 2026, selling an estimated $107K and leaving 7,060 shares worth $1.38M. The position accounts for 0.25% of the portfolio, ranked #52.

Abel Hall LLC first reported a position in KLAC in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.29M in Q2 2026. 756 funds tracked by Wall St. Rank hold KLAC as of Q3 2026.

  • Abel Hall LLC held 7,060 shares of KLA worth $1.38M as of Q3 2026.
  • Abel Hall LLC sold 543 KLA shares in Q3 2026, an estimated $107K.
  • KLA made up 0.25% of Abel Hall LLC's portfolio in Q3 2026, its #52 holding.
  • Abel Hall LLC first reported a position in KLA in Q2 2024 and has held it in 9 quarters since.
  • Abel Hall LLC's KLA position peaked at $2.29M in Q2 2026.
  • 756 funds tracked by Wall St. Rank held KLA as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.